Advertisement
Advertisement
U.S. markets close in 3 hours 58 minutes
Advertisement
Advertisement
Advertisement
Advertisement

T2 Biosystems, Inc. (TTOO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.1044-0.0021 (-1.97%)
As of 12:01PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close0.1065
Open0.1043
Bid0.1030 x 1800
Ask0.1058 x 900
Day's Range0.1011 - 0.1060
52 Week Range0.0890 - 0.9600
Volume2,751,624
Avg. Volume43,347,889
Market Cap36.805M
Beta (5Y Monthly)0.50
PE Ratio (TTM)N/A
EPS (TTM)-0.3350
Earnings DateNov 02, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.20
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for TTOO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • T2 Biosystems, Inc.
    BRKR: Lowering target price to $54.00BRUKER CORP has an Investment Rating of HOLD; a target price of $54.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    9 days agoArgus Research
View more
  • GlobeNewswire

    T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million

    Advances U.S. Clinical Trials and FDA Submission for T2Resistance and T2Biothreat PanelsLEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, is providing

  • Benzinga

    T2 Biosystems Stock Jumps On Distribution Pact In Baltic Countries

    T2 Biosystems Inc (NASDAQ: TTOO) executed a territory-exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx Instruments, along with T2Bacteria, T2Candida, and T2Resistance Panels, through the distributor. Related: T2 Biosystems Q2 Sales Below Expectations, Sticks To Annual Guidance. The execution of this exclusive distribution agreement further expands T2 Biosystems' commercialization. Epide

  • GlobeNewswire

    T2 Biosystems Announces Commercial Expansion Through Distributor in Baltic Region

    LEXINGTON, Mass., Sept. 22, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of a territory exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms of the agreement, T2 Biosystems will sell T2Dx® Instruments, along with T2Bacteria®, T2Candida® and T2Resistance® Panels through the distributor. The execution of

Advertisement
Advertisement